secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0001493152-23-044022
Event type: debt
Sentiment:  negative
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $45K convertible note with 35% discount conversion
---------------------------------------------------------------------------

- Principal $45,000; maturity Sept 15, 2024; interest 8% (22% default); issued to 1800 Diagonal Lending LLC.
- Conversion price at 35% discount to avg of lowest 3 trading prices over 10 days prior; 4.99% beneficial ownership cap.
- Company may prepay within 180 days at escalating premiums: 110% to 129% of principal plus interest.
- Proceeds for general working capital; company also pays $5,000 buyer's legal/due diligence fees.
- Note issued under Section 4(a)(2)/Reg D private placement exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223044022/0001493152-23-044022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223044022/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-044022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer